These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8537373)

  • 1. Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc.
    Zhou MM; Harlan JE; Wade WS; Crosby S; Ravichandran KS; Burakoff SJ; Fesik SW
    J Biol Chem; 1995 Dec; 270(52):31119-23. PubMed ID: 8537373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
    Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
    O'Bryan JP; Lambert QT; Der CJ
    J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine.
    Trüb T; Choi WE; Wolf G; Ottinger E; Chen Y; Weiss M; Shoelson SE
    J Biol Chem; 1995 Aug; 270(31):18205-8. PubMed ID: 7543098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
    O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphotyrosine binding domains of Shc and insulin receptor substrate 1 recognize the NPXpY motif in a thermodynamically distinct manner.
    Farooq A; Plotnikova O; Zeng L; Zhou MM
    J Biol Chem; 1999 Mar; 274(10):6114-21. PubMed ID: 10037694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tyrosine-phosphorylated protein of 140 kD is constitutively associated with the phosphotyrosine binding domain of Shc and the SH3 domains of Grb2 in acute myeloid leukemia cells.
    Jücker M; Schiffer CA; Feldman RA
    Blood; 1997 Mar; 89(6):2024-35. PubMed ID: 9058724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling.
    Ravichandran KS; Igras V; Shoelson SE; Fesik SW; Burakoff SJ
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5275-80. PubMed ID: 8643566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
    van der Geer P; Wiley S; Pawson T
    Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the phosphotyrosine-binding domain of the Drosophila Shc protein.
    Li SC; Lai KM; Gish GD; Parris WE; van der Geer P; Forman-Kay J; Pawson T
    J Biol Chem; 1996 Dec; 271(50):31855-62. PubMed ID: 8943228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
    Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
    Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor.
    Batzer AG; Blaikie P; Nelson K; Schlessinger J; Margolis B
    Mol Cell Biol; 1995 Aug; 15(8):4403-9. PubMed ID: 7542744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of residues within the SHC phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction.
    Yajnik V; Blaikie P; Bork P; Margolis B
    J Biol Chem; 1996 Jan; 271(4):1813-6. PubMed ID: 8567619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
    van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo.
    Isakoff SJ; Yu YP; Su YC; Blaikie P; Yajnik V; Rose E; Weidner KM; Sachs M; Margolis B; Skolnik EY
    J Biol Chem; 1996 Feb; 271(8):3959-62. PubMed ID: 8626723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain.
    Dikic I; Batzer AG; Blaikie P; Obermeier A; Ullrich A; Schlessinger J; Margolis B
    J Biol Chem; 1995 Jun; 270(25):15125-9. PubMed ID: 7541035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.
    Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE
    Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation.
    Blaikie PA; Fournier E; Dilworth SM; Birnbaum D; Borg JP; Margolis B
    J Biol Chem; 1997 Aug; 272(33):20671-7. PubMed ID: 9252386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphorylation of shc in response to B cell antigen receptor engagement depends on the SHIP inositol phosphatase.
    Ingham RJ; Okada H; Dang-Lawson M; Dinglasan J; van Der Geer P; Kurosaki T; Gold MR
    J Immunol; 1999 Dec; 163(11):5891-5. PubMed ID: 10570274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.